Citation: | HUANG Qian, XU Xin, SHAO Jie, ZHANG Fang, CAI Chengjun, HUANG Jiaoling, LIU Wei, ZHANG Shengbing. Potentially inappropriate medications management strategies for elderly patients with coexisting diseases based on the survey of general practitioners in Pudong New Area[J]. Chinese Journal of General Practice, 2023, 21(6): 911-915. doi: 10.16766/j.cnki.issn.1674-4152.003013 |
[1] |
苏甦, 高灵灵, 马文瑶, 等. 门诊老年患者潜在不适当用药对全因住院时长和住院药品费用的影响[J]. 中国医院药学杂志, 2022, 42(14): 1488-1493. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ202214018.htm
SU S, GAO L L, MA W Y, et al. The impact of exposure of different numbers of potentially inappropriate medications among old outpatients on all-cause hospitalization expenditures and length of stay[J]. Chinese Journal of Hospital Pharmacy, 2022, 42(14): 1488-1493. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ202214018.htm
|
[2] |
李权才. 西药处方不合理用药的问题分析及对策[J]. 国际临床研究杂志, 2022, 6(2): 121-124. https://www.cnki.com.cn/Article/CJFDTOTAL-XTYX202209046.htm
LI Q C. Analysis and countermeasures of irrational use of Western medicine prescription[J]. International Journal of Clinical Research, 2022, 6(2): 121-124. https://www.cnki.com.cn/Article/CJFDTOTAL-XTYX202209046.htm
|
[3] |
崔娟, 毛凡, 王志会. 中国老年居民多种慢性病共存状况分析[J]. 中国公共卫生, 2016, 32(1): 66-69. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGW201601022.htm
CUI J, MAO F, WANG Z H. Comorbidity of common chronic diseases among the elderly in China[J]. Chinese Journal of Public Health, 2016, 32(1): 66-69. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGW201601022.htm
|
[4] |
刘葳, 于德华, 金花, 等. 社区老年多病共存患者多重用药情况评价研究[J]. 中国全科医学, 2020, 23(13): 1592-1598. doi: 10.12114/j.issn.1007-9572.2020.00.026
LU W, YU D H, JIN H, et al. Analysis and evaluation of multiple drug use among elderly patients with multiple chronic conditions in community[J]. Chinese General Practice, 2020, 23(13): 1592-1598. doi: 10.12114/j.issn.1007-9572.2020.00.026
|
[5] |
杜红丽, 陈运转. 类风湿关节炎患者共存疾病的临床特征及危险因素分析[J]. 黑龙江医学, 2021, 45(19): 2040-2041. doi: 10.3969/j.issn.1004-5775.2021.19.009
DU H L, CHEN Y Z. Analysis of clinical features and risk factors of co-existing diseases in patients with rheumatoid arthritis[J]. Heilong Medical Jouranl, 2021, 45(19): 2040-2041. doi: 10.3969/j.issn.1004-5775.2021.19.009
|
[6] |
刘淼, 李嘉琦, 吕宪玉, 等. ≥80岁老年人多重用药现况及影响因素分析[J]. 中国公共卫生, 2017, 33(3): 412-414. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGW201703018.htm
LIU M, LI J Q, LYU X Y, et al. Prevalence and influencing factors of polypharmacy among persons aged 80 years or older[J]. Chinese Journal of Public Health, 2017, 33(3): 412-414. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGW201703018.htm
|
[7] |
杨楠. 真如社区老年高血压合并糖尿病患者合理用药习惯调查[J]. 中华全科医学, 2016, 14(8): 1351-1352, 1369. doi: 10.16766/j.cnki.issn.1674-4152.2016.08.035
YANG N. Survey about the habit of rational drug usage of the elderly hypertensive patients with diabetes mellitus in Zhenru community[J]. Chinese Journal of General Practice, 2016, 14(8): 1351-1352, 1369. doi: 10.16766/j.cnki.issn.1674-4152.2016.08.035
|
[8] |
杨晓欧, 庄宁, 张琳, 等. Beers标准和STOPP标准在社区老年患者潜在不适当用药中的评估作用[J]. 临床合理用药杂志, 2017, 10(21): 95-97. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201721049.htm
YANG X O, ZHUANG N, ZHANG L, et al. Role of Beers criteria and STOPP criteria in evaluating potential inappropriate drug use in elderly patients in the community[J]. Chinese Journal of Clinical Rational Drug Use, 2017, 10(21): 95-97. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201721049.htm
|
[9] |
LIU J W. Discussion on the phenomenon of irrational clinical drug use and improvement measures[J]. Med Res, 2020, 2(1): 5-9.
|
[10] |
贺苗, 高丽蓉, 井泉. 高龄老年患者不合理用药情况调查及影响因素分析[J]. 贵州医药, 2022, 46(7): 1106-1107. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI202207054.htm
HE M, GAO L R, JING Q. Investigation and influencing factors analysis of irrational drug use in elderly patients[J]. Guizhou Medical Journal, 2022, 46(7): 1106-1107. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI202207054.htm
|
[11] |
罗瑶, 邓学学, 徐晓茹, 等. 基于大数据老年多重慢性病风险预测模型构建探究[J]. 中华全科医学, 2021, 19(12): 1979-1982. doi: 10.16766/j.cnki.issn.1674-4152.002216
LUO Y, DENG X X, XU X R, et al. Research on the establishment of a risk prediction model for multiple chronic diseases in the elderly based on big data[J]. Chinese Journal of General Practice, 2021, 19(12): 1979-1982. doi: 10.16766/j.cnki.issn.1674-4152.002216
|
[12] |
范立萍, 弥曼, 李雪萍, 等. 西安市全科医生对于儿童普通感冒的诊疗认知及其影响因素研究[J]. 中华全科医学, 2019, 17(10): 1714-1717. doi: 10.16766/j.cnki.issn.1674-4152.001038
FAN L P, MI M, LI X P, et al. A Study of the diagnostic perception of the primary care physicians in Xi'an city concerning of the common cold among the children and the influencing factors[J]. Chinese Journal of General Practice, 2019, 17(10): 1714-1717. doi: 10.16766/j.cnki.issn.1674-4152.001038
|
[13] |
陈慧丽, 邵娜赛, 戚锡铅. 处方审核在改善内科口服类中成药不合理使用及医疗冲突中的效果探究[J]. 中医药管理杂志, 2022, 30(9): 81-82. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYG202209032.htm
CHEN H L, SHAO N S, QI X Q. Study on the effect of prescription review in improving the irrational use of oral proprietary Chinese medicine and medical conflicts[J]. Journal of Traditional Chinese Medicine Management, 2022, 30(9): 81-82. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYG202209032.htm
|
[14] |
陈伟兰. 实施重点监控药品管控措施对促进临床合理用药的干预效果[J]. 中国医药科学, 2022, 12(6): 113-115, 127. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX202206028.htm
CHEN W L. Analysis on the intervention effect of key monitored drug control measures on promoting rational medication in clinic[J]. China Medicine And Pharmacy, 2022, 12(6): 113-115, 127. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX202206028.htm
|
[15] |
张楠, 夏文斌, 杨慧鹃, 等. DRGs付费背景下临床药师参与临床路径合理用药管理模式探讨[J]. 中国药事, 2022, 36(2): 194-202. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYS202202012.htm
ZHANG N, XIA W B, YANG H J, et al. Study on the management mode of rational drug use with clinical pharmacists' participation in clinical pathway under the background of drgs payment[J]. Chinese Pharmaceutical Affairs, 2022, 36(2): 194-202. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYS202202012.htm
|